Myriad Genetics, Inc. (MYGN) SEC filings

MYGN SEC filings moved a median of -0.92% by the close. MYGN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MYGN overview →

64 measured MYGN SEC filing events.

Where these MYGN SEC filings landedvs 64 measured MYGN SEC filing reactions
MYGN SEC filingMiddle 50% · -4.67% to +3.25%Zero: 0.00%Median: -0.92%Median -0.92%-6.00%0+6.00%
Middle 50% of MYGN SEC filing reactions-4.67% to +3.25%
Median reaction (to close)-0.92%
Measured reactions64
Point-in-time · zero look-ahead

Half of the 64 MYGN SEC filing events with a measured close landed between -4.67% and +3.25%; 39% closed up.

DateHeadlineEvent5-minTo close
Form 8-K MYRIAD GENETICS INC For: Oct 06SEC filing · Form 8-K+0.12%-2.33%
Form 8-K MYRIAD GENETICS INC For: Sep 15SEC filing · Form 8-K+3.39%+0.78%
Form 10-Q MYRIAD GENETICS INC For: Jun 30SEC filing · Form 10-Q+8.00%-4.67%
Form 8-K MYRIAD GENETICS INC For: Jul 30SEC filing · Form 8-K+8.00%-4.67%
Form 8-K MYRIAD GENETICS INC For: Jun 17SEC filing · Form 8-K+0.91%+4.99%
Form 8-K MYRIAD GENETICS INC For: Jun 04SEC filing · Form 8-K-1.49%-2.56%
Form S-8 MYRIAD GENETICS INCSEC filing · Form S-8-1.49%-2.56%
Form 10-Q MYRIAD GENETICS INC For: Mar 31SEC filing · Form 10-Q+2.01%-2.84%
Form 8-K MYRIAD GENETICS INC For: May 05SEC filing · Form 8-K+2.01%-2.84%
Form ARS MYRIAD GENETICS INC For: Dec 31SEC filing · Form ARS+2.47%+7.01%
Form DEF 14A MYRIAD GENETICS INC For: Dec 31SEC filing · Form DEF+2.47%+7.01%
Form DEFA14A MYRIAD GENETICS INCSEC filing · Form DEFA14A+2.47%+7.01%
Form EFFECT MYRIAD GENETICS INCSEC filing · Form EFFECT+0.78%+0.39%
Form 10-K MYRIAD GENETICS INC For: Dec 31SEC filing · Form 10-K+0.45%+7.90%
Form S-3 MYRIAD GENETICS INCSEC filing · Form S-3+0.45%+7.90%
Form 8-K MYRIAD GENETICS INC For: Feb 23SEC filing · Form 8-K-12.93%-20.47%
Form 8-K MYRIAD GENETICS INC For: Jan 12SEC filing · Form 8-K+3.13%-1.94%
Form 10-Q MYRIAD GENETICS INC For: Sep 30SEC filing · Form 10-Q-2.02%-12.94%
Form 8-K/A MYRIAD GENETICS INC For: Nov 03SEC filing · Form 8-K-2.02%-12.94%
Form 8-K MYRIAD GENETICS INC For: Nov 03SEC filing · Form 8-K-2.02%-12.94%
Form 8-K MYRIAD GENETICS INC For: Oct 01SEC filing · Form 8-K+0.26%+0.00%
Form 8-K MYRIAD GENETICS INC For: Sep 29SEC filing · Form 8-K+0.06%-0.13%
Form 8-K MYRIAD GENETICS INC For: Aug 15SEC filing · Form 8-K+1.23%+0.00%
Form 10-Q MYRIAD GENETICS INC For: Jun 30SEC filing · Form 10-Q+4.60%+8.62%
Form 8-K MYRIAD GENETICS INC For: Aug 05SEC filing · Form 8-K+4.60%+8.62%
Form 8-K MYRIAD GENETICS INC For: Jul 31SEC filing · Form 8-K-0.99%-5.18%
Form 8-K MYRIAD GENETICS INC For: Jun 05SEC filing · Form 8-K+0.81%+3.25%
Form S-8 MYRIAD GENETICS INCSEC filing · Form S-8+0.81%+3.25%
Form 10-Q MYRIAD GENETICS INC For: Mar 31SEC filing · Form 10-Q-7.11%-25.09%
Form 8-K MYRIAD GENETICS INC For: May 06SEC filing · Form 8-K-7.11%-25.09%
Form S-8 MYRIAD GENETICS INCSEC filing · Form S-8+0.69%+3.99%
Form ARS MYRIAD GENETICS INC For: Dec 31SEC filing · Form ARS+1.11%-1.97%
Form DEF 14A MYRIAD GENETICS INC For: Dec 31SEC filing · Form DEF+1.11%-1.97%
Form DEFA14A MYRIAD GENETICS INCSEC filing · Form DEFA14A+1.11%-1.97%
Form 10-K MYRIAD GENETICS INC For: Dec 31SEC filing · Form 10-K-1.20%-4.24%
Form 8-K MYRIAD GENETICS INC For: Feb 24SEC filing · Form 8-K+13.75%+18.71%
Form 8-K MYRIAD GENETICS INC For: Jan 15SEC filing · Form 8-K-2.12%-7.26%
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assayPress release+3.32%+3.25%
Form 8-K MYRIAD GENETICS INC For: Dec 10SEC filing · Form 8-K-0.49%-5.29%
Form 8-K MYRIAD GENETICS INC For: Nov 26SEC filing · Form 8-K-0.46%-0.31%
Form 10-Q MYRIAD GENETICS INC For: Sep 30SEC filing · Form 10-Q+3.19%-3.33%
Form 8-K MYRIAD GENETICS INC For: Nov 07SEC filing · Form 8-K+3.19%-3.33%
Form 8-K MYRIAD GENETICS INC For: Oct 09SEC filing · Form 8-K+0.00%-8.11%
Form 8-K MYRIAD GENETICS INC For: Sep 04SEC filing · Form 8-K+0.26%-5.83%
Form 10-Q MYRIAD GENETICS INC For: Jun 30SEC filing · Form 10-Q-2.71%-6.72%
Form 8-K MYRIAD GENETICS INC For: Aug 06SEC filing · Form 8-K-2.71%-6.72%
Form 8-K MYRIAD GENETICS INC For: Jun 06SEC filing · Form 8-K-0.68%+0.68%
Form 8-K MYRIAD GENETICS INC For: Jun 03SEC filing · Form 8-K-0.61%+1.31%
Form 10-Q MYRIAD GENETICS INC For: Mar 31SEC filing · Form 10-Q+1.13%+2.00%
Form 8-K MYRIAD GENETICS INC For: May 07SEC filing · Form 8-K+1.13%+2.00%
Form ARS MYRIAD GENETICS INC For: Dec 31SEC filing · Form ARS-1.35%-0.32%
Form DEF 14A MYRIAD GENETICS INC For: Dec 31SEC filing · Form DEF-1.35%-0.32%
Form DEFA14A MYRIAD GENETICS INCSEC filing · Form DEFA14A-1.35%-0.32%
Form 10-K MYRIAD GENETICS INC For: Dec 31SEC filing · Form 10-K-0.88%-7.05%
Form 8-K MYRIAD GENETICS INC For: Feb 27SEC filing · Form 8-K-0.88%-7.05%
Form 8-K MYRIAD GENETICS INC For: Jan 10SEC filing · Form 8-K-0.91%+3.89%
Form 8-K MYRIAD GENETICS INC For: Dec 15SEC filing · Form 8-K+3.09%+3.70%
Form 8-K MYRIAD GENETICS INC For: Nov 08SEC filing · Form 8-K-0.35%-1.52%
Form 8-K MYRIAD GENETICS INC For: Nov 08SEC filing · Form 8-K+0.29%-3.78%
Form S-3ASR MYRIAD GENETICS INCSEC filing · Form S-3ASR+0.29%-3.78%
Form 10-Q MYRIAD GENETICS INC For: Sep 30SEC filing · Form 10-Q+6.02%+3.74%
Form 8-K MYRIAD GENETICS INC For: Nov 06SEC filing · Form 8-K+6.02%+3.74%
Form 8-K MYRIAD GENETICS INC For: Nov 01SEC filing · Form 8-K-1.70%+1.22%
Form 8-K MYRIAD GENETICS INC For: Oct 31SEC filing · Form 8-K-1.70%+1.22%
That’s how MYGN usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More MYGN: earnings → · analyst actions → · MYGN overview →

Other Healthcare names and their SEC filings

TickerEventsMedian 30-min% positive
VICAL (VICL)574-0.00%38%
Becton, Dickinson and Company (BDX)573-0.01%50%
Tilray Brands, Inc. (TLRY)558-0.32%41%
PERNIX THERAPEUTICS HOLDINGS (PTX)557-0.19%41%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.